Tazloc-AM 80 Tablet
By Tazloc-AM
Rx
10 Tablet in a Strip

Composition
Telmisartan(80mg) + Amlodipine(5mg)

Manufacturer - USV Ltd
Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai - 400 088. , India.

Expires on or after
January, 2026

liver
When using Tazloc-AM 80 Tablet, it is important to exercise caution if you have liver disease. Your doctor may need to adjust the dosage accordingly, so consulting them is essential. For those with a history of liver diseases or conditions, extra care is advised when taking Teltas Trio 40/10/6.5 Tablet 15's. Your doctor may modify the dose based on your condition. It is advisable to refrain from using Teltas Trio 40/10/6.5 Tablet 15's in cases of severe liver disease. Remember to always seek guidance from your doctor to ensure safe and appropriate usage of these medications.

kidney
Tazloc-AM 80 Tablet is safe for use in patients with kidney disease without the need for dose adjustment. If you have a history of kidney conditions, take Teltas Trio 40/10/6.5 Tablet with caution. Your doctor may adjust the dose as needed, but avoid it if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Tazloc-AM 80 Tablet due to potential adverse effects like low blood pressure, dizziness, fainting, light-headedness, or headaches.

driving
Tazloc-AM 80 Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, impacting driving ability. Exercise caution while driving if you experience these symptoms. Similarly, Teltas Trio 40/10/6.5 Tablet 15's may also induce dizziness or tiredness, advising against driving in such cases.

pregnancy
Tazloc-AM 80 Tablet is unsafe during pregnancy due to risks to the developing baby. It may be prescribed in life-threatening situations if benefits outweigh risks. Consult your doctor before using. Teltas Trio 40/10/6.5 Tablet 15's is not recommended for pregnant women as it may harm the unborn baby. Consult a doctor if pregnant.

breastfeeding
Tazloc-AM 80 Tablet is likely safe during breastfeeding. Limited evidence shows no significant risk to the baby. For Teltas Trio 40/10/6.5 Tablet 15's, it may harm the baby through breast milk; avoid it while breastfeeding and seek medical advice.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹227.45
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024